PMC:7755033 / 83207-84014 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1472","span":{"begin":104,"end":106},"obj":"Species"},{"id":"1473","span":{"begin":272,"end":274},"obj":"Species"},{"id":"1474","span":{"begin":549,"end":551},"obj":"Species"},{"id":"1475","span":{"begin":191,"end":209},"obj":"Chemical"},{"id":"1476","span":{"begin":214,"end":224},"obj":"Chemical"},{"id":"1477","span":{"begin":373,"end":383},"obj":"Chemical"},{"id":"1478","span":{"begin":388,"end":398},"obj":"Chemical"},{"id":"1479","span":{"begin":454,"end":464},"obj":"Chemical"},{"id":"1480","span":{"begin":661,"end":673},"obj":"Chemical"},{"id":"1481","span":{"begin":730,"end":740},"obj":"Chemical"}],"attributes":[{"id":"A1472","pred":"tao:has_database_id","subj":"1472","obj":"Tax:126910"},{"id":"A1473","pred":"tao:has_database_id","subj":"1473","obj":"Tax:126910"},{"id":"A1474","pred":"tao:has_database_id","subj":"1474","obj":"Tax:126910"},{"id":"A1475","pred":"tao:has_database_id","subj":"1475","obj":"MESH:D006886"},{"id":"A1476","pred":"tao:has_database_id","subj":"1476","obj":"MESH:C557213"},{"id":"A1477","pred":"tao:has_database_id","subj":"1477","obj":"MESH:D000069449"},{"id":"A1479","pred":"tao:has_database_id","subj":"1479","obj":"MESH:C557213"},{"id":"A1480","pred":"tao:has_database_id","subj":"1480","obj":"MESH:D011342"},{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"MESH:C557213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The obtained results have been presented in Table 15. As is evident from Table 15, none of the analyzed WS phytoconstituents had any mutagenic effects in contrast to standard reference drugs hydroxychloroquine and poziotinib which displayed high mutagenicity. Most of the WS phytoconstituents displayed little to no tumorigenicity in comparison to standard reference drugs cinacalcet and oberadilol which exhibited a high tendency for tumorigenicity and poziotinib which exhibited a mild tumorigenicity. The irritant and reproductive effects of the WS phytoconstituents were also predicted to be from negligible to none, in contrast to standard reference drugs procainamide which was predicted to possess high adverse effects and poziotinib that was predicted to have mild irritant and reproductive effects."}

{"project":"LitCovid-sentences","denotations":[{"id":"T845","span":{"begin":0,"end":53},"obj":"Sentence"},{"id":"T846","span":{"begin":54,"end":259},"obj":"Sentence"},{"id":"T847","span":{"begin":260,"end":503},"obj":"Sentence"},{"id":"T848","span":{"begin":504,"end":807},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The obtained results have been presented in Table 15. As is evident from Table 15, none of the analyzed WS phytoconstituents had any mutagenic effects in contrast to standard reference drugs hydroxychloroquine and poziotinib which displayed high mutagenicity. Most of the WS phytoconstituents displayed little to no tumorigenicity in comparison to standard reference drugs cinacalcet and oberadilol which exhibited a high tendency for tumorigenicity and poziotinib which exhibited a mild tumorigenicity. The irritant and reproductive effects of the WS phytoconstituents were also predicted to be from negligible to none, in contrast to standard reference drugs procainamide which was predicted to possess high adverse effects and poziotinib that was predicted to have mild irritant and reproductive effects."}